State Of Wyoming Adagio Therapeutics, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	N/A	68 Added 43.31%	225 $0
Q1 2023 May 12, 2023	SELL	N/A	-7 Reduced 4.27%	157 $0
Q4 2022 Feb 14, 2023	BUY	$3.08 - $4.05 $372 - $490	121 Added 281.4%	164 $0
Q3 2022 Nov 14, 2022	BUY	$2.97 - $4.83 $127 - $207	43 New	43 $0
Q2 2022 Aug 15, 2022	SELL	$2.54 - $4.52 $1,887 - $3,358	-743 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.81 - $10.77 $167 - $473	-44 Reduced 5.59%	743 $3,000
Q4 2021 Feb 11, 2022	BUY	$6.35 - $47.04 $4,997 - $37,020	787 New	787 $6,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.